Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Citi
McKesson
Johnson and Johnson
US Army
Deloitte
Medtronic
Chubb
Farmers Insurance
Mallinckrodt

Generated: October 22, 2017

DrugPatentWatch Database Preview

FORTAZ IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Fortaz In Plastic Container, and when can generic versions of Fortaz In Plastic Container launch?

Fortaz In Plastic Container is a drug marketed by Teligent and is included in one NDA.

The generic ingredient in FORTAZ IN PLASTIC CONTAINER is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.

Summary for Tradename: FORTAZ IN PLASTIC CONTAINER

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list17
Clinical Trials: see list470
Patent Applications: see list23
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FORTAZ IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent
FORTAZ IN PLASTIC CONTAINER
ceftazidime sodium
INJECTABLE;INJECTION050634-001Apr 28, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ IN PLASTIC CONTAINER
ceftazidime sodium
INJECTABLE;INJECTION050634-002Apr 28, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ IN PLASTIC CONTAINER
ceftazidime sodium
INJECTABLE;INJECTION050634-003Apr 28, 1989RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
UBS
Queensland Health
US Army
Chinese Patent Office
Baxter
Julphar
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot